TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06784973

Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Study was terminated by Sponsor; the decision was not due to any safety findings.”

The sponsor’s own words in the registry.

Life of this trial

202520262027Registered2025-01-15Started2025-03-05Stopped2025-04-16Results posted2026-06-08

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Gilead Sciences
Sponsor type
Industry
Conditions
RSV Infection
Interventions
Obeldesivir; Obeldesivir Placebo
Participants
4
Sites
56
Countries
Japan, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.